Role of pump prime in the etiology and pathogenesis of cardiopulmonary bypass-associated acidosis. 2000

F J Liskaser, and R Bellomo, and M Hayhoe, and D Story, and S Poustie, and B Smith, and A Letis, and M Bennett
Departments of Anaesthesia and Intensive Care, Austin and Repatriation Medical Centre, Melbourne, Australia.

BACKGROUND The development of metabolic acidosis during cardiopulmonary bypass (CPB) is well recognized but poorly understood. The authors hypothesized that the delivery of pump prime fluids is primarily responsible for its development. Accordingly, acid-base changes induced by the establishment of CPB were studied using two types of priming fluid (Haemaccel, a polygeline solution, and Ringer's Injection vs. Plasmalyte 148) using quantitative biophysical methods. METHODS A prospective, double-blind, randomized trial was conducted at a tertiary institution with 22 patients undergoing CPB for coronary artery bypass surgery. Sampling of arterial blood was performed at three time intervals: before CPB (t1), 2 min after initiation of CPB at full flows (t2), and at the end of the case (t3). Measurements of Na+, K+, Mg2+, Cl-, HCO3-, phosphate, Ca2+, albumin, lactate, and arterial blood gases at each collection point were performed. Results were analyzed in a quantitative manner. RESULTS Immediately on delivery of pump prime fluids, all patients developed a metabolic acidosis (base excess: 0. 95 mEq/l (t1) to -3.65 mEq/l (t2) (P < 0.001) for Haemaccel-Ringer's and 1.17 mEq/l (t1) to -3.20 mEq/l (t2). The decrease in base excess was the same for both primes (-4.60 vs. -4.37; not significant). However, the mechanism of metabolic acidosis was different. With the Haemaccel-Ringer's prime, the metabolic acidosis was hyperchloremic (Delta Cl-, +9.50 mEq/l; confidence interval, 7.00-11.50). With Plasmalyte 148, the acidosis was induced by an increase in unmeasured anions, most probably acetate and gluconate. The resolution of these two processes was different because the excretion of chloride was slower than that of the unmeasured anions (Delta base excess from t1 to t3 = -1.60 for Haemaccel-Ringer's vs. +1.15 for Plasmalyte 148; P = 0.0062). CONCLUSIONS Cardiopulmonary bypass-induced metabolic acidosis appears to be iatrogenic in nature and derived from the effect of pump prime fluid on acid-base balance. The extent of such acidosis and its duration varies according to the type of pump prime.

UI MeSH Term Description Entries
D007552 Isotonic Solutions Solutions having the same osmotic pressure as blood serum, or another solution with which they are compared. (From Grant & Hackh's Chemical Dictionary, 5th ed & Dorland, 28th ed) Solutions, Isotonic
D010952 Plasma Substitutes Any liquid used to replace blood plasma, usually a saline solution, often with serum albumins, dextrans or other preparations. These substances do not enhance the oxygen- carrying capacity of blood, but merely replace the volume. They are also used to treat dehydration. Blood Expanders,Plasma Volume Expanders,Expanders, Blood,Expanders, Plasma Volume,Substitutes, Plasma,Volume Expanders, Plasma
D011097 Polygeline A 3.5 per cent colloidal solution containing urea-cross-linked polymerized peptides. It has a molecular weight of approximately 35,000 and is prepared from gelatin and electrolytes. The polymeric solution is used as a plasma expander. Gelofusine,Haemaccel,Thomaegelin,Gelofusines,Haemaccels,Polygelines,Thomaegelins
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077331 Ringer's Solution An isotonic solution; the base contains SODIUM CHLORIDE; POTASSIUM CHLORIDE; and CALCIUM CHLORIDE. Other chemicals, such as SODIUM BICARBONATE or acetate salts may be added, as needed for pH buffering, or as an energy source. Ringers Solution,Ringer Solution
D000136 Acid-Base Equilibrium The balance between acids and bases in the BODY FLUIDS. The pH (HYDROGEN-ION CONCENTRATION) of the arterial BLOOD provides an index for the total body acid-base balance. Anion Gap,Acid-Base Balance,Acid Base Balance,Acid Base Equilibrium,Anion Gaps,Balance, Acid-Base,Equilibrium, Acid-Base,Gap, Anion,Gaps, Anion
D000138 Acidosis A pathologic condition of acid accumulation or depletion of base in the body. The two main types are RESPIRATORY ACIDOSIS and metabolic acidosis, due to metabolic acid build up. Metabolic Acidosis,Acidoses,Acidoses, Metabolic,Acidosis, Metabolic,Metabolic Acidoses

Related Publications

F J Liskaser, and R Bellomo, and M Hayhoe, and D Story, and S Poustie, and B Smith, and A Letis, and M Bennett
July 1999, Intensive care medicine,
F J Liskaser, and R Bellomo, and M Hayhoe, and D Story, and S Poustie, and B Smith, and A Letis, and M Bennett
January 2002, Indian journal of clinical biochemistry : IJCB,
F J Liskaser, and R Bellomo, and M Hayhoe, and D Story, and S Poustie, and B Smith, and A Letis, and M Bennett
January 2021, Annals of cardiac anaesthesia,
F J Liskaser, and R Bellomo, and M Hayhoe, and D Story, and S Poustie, and B Smith, and A Letis, and M Bennett
December 2002, Scandinavian cardiovascular journal : SCJ,
F J Liskaser, and R Bellomo, and M Hayhoe, and D Story, and S Poustie, and B Smith, and A Letis, and M Bennett
January 1992, The Annals of thoracic surgery,
F J Liskaser, and R Bellomo, and M Hayhoe, and D Story, and S Poustie, and B Smith, and A Letis, and M Bennett
February 1999, The Annals of thoracic surgery,
F J Liskaser, and R Bellomo, and M Hayhoe, and D Story, and S Poustie, and B Smith, and A Letis, and M Bennett
March 2007, The journal of extra-corporeal technology,
F J Liskaser, and R Bellomo, and M Hayhoe, and D Story, and S Poustie, and B Smith, and A Letis, and M Bennett
August 1987, Journal of cardiothoracic anesthesia,
F J Liskaser, and R Bellomo, and M Hayhoe, and D Story, and S Poustie, and B Smith, and A Letis, and M Bennett
December 1997, Critical care medicine,
F J Liskaser, and R Bellomo, and M Hayhoe, and D Story, and S Poustie, and B Smith, and A Letis, and M Bennett
July 1986, Anesthesia and analgesia,
Copied contents to your clipboard!